Adriacin and acute myeloid leukaemia Patient Reports February 12, 2012



Adriacin Side Effects Report #4565031-X
Adriacin side effect was reported by a Physician from on Jan 13, 2005. Female patient, 41 years of age, was diagnosed with t-cell lymphoma and was treated with Adriacin. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, bone marrow depression, central nervous system lymphoma, cerebellar tumour, cerebral haemorrhage, gingival bleeding, haemorrhagic diathesis, myelodysplastic syndrome. Adriacin dosage: 400 MG CUMULATIVE DOSE. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATIN, CARBOPLATIN, PREDNISOLONE, VINCRISTINE SULPHATE, MITOXANTRONE, CYTARABINE. Patient died on 03/01/2002.

Adriacin Side Effects Report #6003932-6
Adriacin side effect was reported by a Health Professional from JAPAN on Dec 04, 2008. Female patient was diagnosed with breast cancer What is  breast cancer and was treated with Adriacin. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, neoplasm malignant. Adriacin dosage: 68 MG, ONCE EVERY 3 WEEKS. During the same period patient was treated with TAXOL, TRASTUZUMAB, KYTRIL, DECADRON, POLARAMINE. Patient died on 05/27/2008.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Adriacin